- Home
- PSTV vs ACCS Comparison
PSTV vs ACCS Comparison
Compare PSTV & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSTV | ACCS |
|---|---|---|
| Founded | 1996 | 1988 |
| Country | United States | United States |
| Employees | N/A | 91 |
| Industry | Medical/Dental Instruments | Publishing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1M | 22.5M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PSTV | ACCS |
|---|---|---|
| Price | $3.98 | $6.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $55.00 | $14.00 |
| AVG Volume (30 Days) | ★ 178.0K | 12.3K |
| Earning Date | 05-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,213,000.00 | N/A |
| Revenue This Year | $13.20 | $7.40 |
| Revenue Next Year | $261.48 | $8.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.13 | $5.80 |
| 52 Week High | $8.00 | $13.10 |
Technical Indicators
Market Signals| Indicator | PSTV | ACCS |
|---|---|---|
| Relative Strength Index (RSI) | 34.28 | 55.93 |
| Support Level | $0.36 | $6.63 |
| Resistance Level | $6.65 | $8.63 |
| Average True Range (ATR) | 0.35 | 0.35 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 8.64 | 99.09 |
Price Performance
Historical ComparisonAbout PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.